Liposarcoma
2 competing products in clinical development for Liposarcoma.
Pipeline by Phase
Phase 11
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| efatutazone | Daiichi Sankyo | Phase 2 | Completed | 35 |
| Eribulin Mesylate | Eisai | Phase 1 | Active | 33 |